Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
Labarrière N, Pandolfino MC, Gervois N, Khammari A, Tessier MH, Dréno B, Jotereau F. Labarrière N, et al. Among authors: jotereau f. Cancer Immunol Immunother. 2002 Nov;51(10):532-8. doi: 10.1007/s00262-002-0313-3. Epub 2002 Sep 18. Cancer Immunol Immunother. 2002. PMID: 12384804 Free PMC article. Clinical Trial.
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Dréno B, Nguyen JM, Khammari A, Pandolfino MC, Tessier MH, Bercegeay S, Cassidanius A, Lemarre P, Billaudel S, Labarrière N, Jotereau F. Dréno B, et al. Among authors: jotereau f. Cancer Immunol Immunother. 2002 Nov;51(10):539-46. doi: 10.1007/s00262-002-0315-1. Epub 2002 Sep 19. Cancer Immunol Immunother. 2002. PMID: 12384805 Free PMC article. Clinical Trial.
[Passive immunotherapy of melanoma].
Jotereau F, Labarriere N, Gervois N, Pandolfino MC, Dreno B. Jotereau F, et al. Bull Cancer. 2003 Jul;90(7):583-6. Bull Cancer. 2003. PMID: 12957798 Free article. Review. French.
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Khammari A, Nguyen JM, Pandolfino MC, Quereux G, Brocard A, Bercegeay S, Cassidanius A, Lemarre P, Volteau C, Labarrière N, Jotereau F, Dréno B. Khammari A, et al. Among authors: jotereau f. Cancer Immunol Immunother. 2007 Nov;56(11):1853-60. doi: 10.1007/s00262-007-0340-1. Epub 2007 Jun 5. Cancer Immunol Immunother. 2007. PMID: 17549472 Free PMC article. Clinical Trial.
107 results